Literature DB >> 19575725

Eruptive melanocytic naevi following melanotan injection.

P Cousen, G Colver, I Helbling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19575725     DOI： 10.1111/j.1365-2133.2009.09362.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

Review 1.  [Undesirable pigmentation].

Authors:  C Bayerl
Journal:  Hautarzt       Date:  2015-10       Impact factor: 0.751

Review 2.  Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.

Authors:  Elisabeth I Minder; Jasmin Barman-Aksoezen; Xiaoye Schneider-Yin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

3.  [Dermoscopic changes in melanocytic nevi during use of melanotan II].

Authors:  R Mang; D Krahl; T Assmann
Journal:  Hautarzt       Date:  2012-11       Impact factor: 0.751

Review 4.  Topical treatment strategies to manipulate human skin pigmentation.

Authors:  Inbal Rachmin; Stephen M Ostrowski; Qing Yu Weng; David E Fisher
Journal:  Adv Drug Deliv Rev       Date:  2020-02-21       Impact factor: 15.470

5.  Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer.

Authors:  Alberto Meneguzzo; Annalisa Lazzarotto; Mauro Alaibac
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

Review 6.  Melanotan II: a possible cause of renal infarction: review of the literature and case report.

Authors:  Björn Peters; Henrik Hadimeri; Rebecka Wahlberg; Henri Afghahi
Journal:  CEN Case Rep       Date:  2020-01-18

7.  Changes of melanocytic lesions inducedby Melanotan injections and sun bed use ina teenage patient with FAMMM syndrome.

Authors:  Graham W Sivyer
Journal:  Dermatol Pract Concept       Date:  2012-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.